Monday, March 25, 2019

Virtual Reality in Medicine and Healthcare to Generate US$285 million in 2022

Therapy and Training Services have the highest opportunity in VR medical and healthcare segment Virtual Reality (VR) has brought a range of new services into the healthcare industry.  The immersive experience provided by VR...

GCE Launches Groundbreaking New Product: Shadow

GCE Solutions, a global clinical research organization (CRO), announces the launch of Shadow, a powerful new data and document anonymization solution on October 4, 2017. Shadow is designed to assist medical writers and biometrics...

FDA clears first over-the-counter (OTC) carbon monoxide breath sensor for use in smoking cessation...

Carrot Inc.'s Bluetooth-enabled mobile device helps users learn how smoking affects their carbon monoxide levels Carrot Inc. announced today that its Carbon Monoxide Breath Sensor System has been cleared by the U.S. Food and...

RWS Expands Global Offering with RWS Life Sciences

The acquisition of LUZ, Inc. and Corporate Translations, Inc. strengthens RWS' market leadership and continued growth of life science language services On October 1, 2017 RWS, the world's leading provider of translation, intellectual property, life sciences...

ADM Tronics Prepares New Respiratory Therapy Device for Market

ADM Tronics Unlimited, Inc. (OTCQB - ADMT) is in the final stage of developing the Alvio™ device, a new technology it has had under development pursuant to its previously announced agreement with QOL...

Boston Scientific Announces Agreement to Acquire Apama Medical

Acquisition to Strengthen Company's Electrophysiology Portfolio and Expand into "Single-Shot" Balloon Pulmonary Vein Isolation Treatments for Patients with Atrial Fibrillation Boston Scientific Corporation today announced a definitive agreement to acquire Apama Medical Inc., a...

Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

Novel Compound with Potential for Early Detection and to Guide Treatment of Colorectal Cancer Edinburgh Molecular Imaging (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces it has commenced a...

New Models and Approaches to Condition Management Leading to Accelerated Growth of Solutions

New Chilmark Research report assesses maturity of solution features, sets forth rationale for rapid growth. Key healthcare stakeholders are accelerating the adoption of more personalized and holistic approaches to chronic condition management, driven by...

Alzheimer’s Disease: Cannabis Formulation Shows Promise

Known as America's most expensive disease, with an estimated cost to the U.S. economy of 6 billion in 2016, Alzheimer's disease (AD) affects more than 5.3 million Americans. Over the next 20 years, the number of...

FDA approves Mylotarg for treatment of acute myeloid leukemia

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also...

Connect with us

4,514FansLike
1,007FollowersFollow
12,053FollowersFollow

Popular Posts